Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Millennium Pharmaceuticals Inc
Millennium Pharmaceuticals Inc Intellectual Property Group
Millennium Pharmaceuticals Inc_20131212
  

Millennium Pharmaceuticals Inc patents

Recent patent applications related to Millennium Pharmaceuticals Inc. Millennium Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Millennium Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Millennium Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Millennium Pharmaceuticals Inc-related inventors




Date Millennium Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
08/03/17Heteroaryl compounds useful as inhibitors of sumo activating enzyme
08/03/17Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
07/06/17Crystalline forms of sodium 4--2-methoxybenzoate
06/22/17Quinoxaline compounds and uses thereof
06/08/17Method of treatment of nasopharyngeal cancer
06/08/17Compounds useful as raf kinase inhibitors
05/18/17Inhibitors of e1 activating enzymes
04/20/17Biomarkers of response to nae inhibitors
04/20/17E1 enzyme mutants and uses thereof
03/23/17Antibodies which bind human cxcr3
03/16/17Heteroaryls and uses thereof
03/16/17Substituted pyrrolo[2,3-d]pyrimidines
02/23/17Heteroaryl compounds useful as inhibitors of e1 activating enzymes
02/09/17Methods of treatment of cancer
02/09/17Anti-psyk antibody molecules and use of same for syk-targeted therapy
01/26/17Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy
01/05/17Hydrochloride salt of((1s,2s,4r)-4--2-hydroxycyclopentyl) methyl sulfamate
01/05/17Heteroaryl compounds useful as inhibitors of sumo activating enzyme
01/05/17Formulation for anti-alpha4beta7 antibody
12/15/16Synthesis of boronic ester and acid compounds
12/08/16Heteroaryl inhibitors of sumo activating enzyme
11/24/16Formulation for anti-alpha4beta7 antibody
11/24/16Formulation for anti-alpha4beta7 antibody
11/17/16Heterocyclic compounds useful as pdk1 inhibitors
11/10/16Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
11/03/16Benzamides and related inhibitors of factor xa
11/03/16Antibodies that bind ov064 and methods of use therefor
10/27/16Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
10/20/16Combination of aurora kinase inhibitors and anti-cd30 antibodies
10/20/16Compounds and compositions for imaging gcc-expressing cells
10/06/16Enhanced treatment regimens using pi3k inhibitors
09/22/16Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
09/22/16Combination of aurora kinase inhibitors and anti-cd20 antibodies
09/01/16Method for the prophylaxis or treatment of systemic lupus erythematosus and/or lupus nephritis
09/01/16Methods and kits for monitoring the effects of immunomodulators on adaptive immunity
08/25/16Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
07/28/16Inhibitor of breast cancer resistance protein (bcrp)
07/14/16Solid pharmaceutical compositions and processes for their production
07/07/16Methods of treating cancer using aurora kinase inhibitors
07/07/16Substituted pyrrolo[2,3-d]pyrimidines
06/30/16Compounds and methods for inhibiting mitotic progression
06/09/16Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
05/12/16Anti-gcc antibody molecules and methods for use of same
05/05/16Novel molecules of the card-related protein family and uses thereof
05/05/16Method for preparing three-dimensional, organotypic cell cultures and uses thereof
04/14/16Novel pharmaceutical salts and polymorphs of a factor xa inhibitor
02/11/16Heteroaryl compounds useful as inhibitors of e1 activating enzymes
02/11/16Substituted hydroxamic acids and uses thereof
02/04/16Hydrochloride salt of((1s,2s,4r)-4--2-hydroxycyclopentyl) methyl sulfamate
02/04/16Substituted hydroxamic acids and uses thereof
02/04/16Chemokine receptor antagonists and methods of use thereof
02/04/16Boronate ester compounds and pharmaceutical compositions thereof
01/14/16Methods of treatment of cancer
01/14/16Heteroaryl compounds useful as inhibitors of sumo activating enzyme
01/14/16Antibodies which bind human cxcr3
12/24/15Administration of nedd8-activating enzyme inhibitor and hypomethylating agent
12/17/15Proteasome inhibitors
12/10/15Process for the synthesis of e1 activating enzyme inhibitors
11/26/15Method for cancer therapy
10/29/15Boronate ester compounds and pharmaceutical compositions thereof
09/10/15Methods for the identification, assessment, and treatment of patients with cancer therapy
08/27/15Biomarkers and methods to predict response to inhibitors and uses thereof
08/13/15Heteroaryls and uses thereof
07/30/15Indole-substituted pyrrolopyrimidinyl inhibitors of uba6
07/02/15Heteroaryl compounds useful as inhibitors of e1 activating enzymes
Patent Packs
07/02/15Biomarkers of response to proteasome inhibitors
06/25/15Thiolactams and uses thereof
06/25/15Heteroaryls and uses thereof
06/25/15Heteroaryls and uses thereof
06/25/15Substituted hydroxamic acids and uses thereof
06/18/15Aurora kinase inhibitors for inhibiting mitotic progression
06/04/15Biomarkers of response to proteasome inhibitors
05/28/15Heteroaryls and uses thereof
05/14/15Quinazoline derivatives as kinase inhibitors
04/30/15Biomarkers of response to nae inhibitors
04/30/15Biomarkers of response to nae inhibitors
04/23/15Preparation of aminotetralin compounds
04/16/15Biomarkers of response to nae inhibitors
04/16/15Substituted hydroxamic acids and uses thereof
03/26/15Humanized anti-ccr2 antibodies and methods of use therefor
Patent Packs
03/19/15Compounds useful as raf kinase inhibitors
03/19/15Process for the synthesis of e1 activating enzyme inhibitors
03/12/15Boronic ester and acid compounds, synthesis and uses
02/05/15Synthesis of boronic ester and acid compounds
01/29/15E1 enzyme mutants and uses thereof
01/15/15Pyridinonyl pdk1 inhibitors
01/08/15Proteasome inhibitors
01/08/15Inhibitors of nedd8-activating enzyme
01/01/15Ccr1 antagonists and methods of use thereof
12/25/14Benzamides and related inhibitors of factor xa
12/25/14Formulation for anti-alpha4beta7 antibody
12/18/14Chemokine receptor antagonists and methods of use thereof
12/11/14Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
12/04/14Crystalline forms of sodium 4--2-methoxybenzoate
11/20/14Formulation for anti-alpha4beta7 antibody
11/13/14Combination of mek inhibitors and selective inhibitors of aurora a kinase
11/06/14Antibodies that bind ov064 and methods of use therefor
11/06/14Substituted hydroxamic acids and uses thereof
10/30/14Anti-gcc antibody molecules and related compositions and methods
10/09/14Heteroaryl compounds useful as inhibitors of e1 activating enzymes
10/02/14Secreted proteins and uses thereof
09/25/14Humanized anti-ccr2 antibodies and methods of use therefor
09/18/14Substituted hydroxamic acids and uses thereof
09/11/14Substituted pyrrolo]2,3-d]pyrimidines
09/11/14Preparation of aminotetralin compounds
09/04/14Administration of nedd8-activating enzyme inhibitor
08/28/14Substituted hydoxamic acids and uses thereof
08/28/14Substituted hydoxamic acids and uses thereof
08/14/14Substituted hydroxamic acids and uses thereof
07/10/14Derivatives of 1-amino-2-cyclobutylethylboronic acid
Social Network Patent Pack
07/10/14Thiolactams and uses thereof
06/26/14Derivatives of 1-amino-2-cyclopropylethylboronic acid
04/17/14Ccr9 inhibitors and methods of use thereof
03/27/14Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
02/13/14Compounds and methods for inhibiting mitotic progression
02/13/14Methods of synthesizing pharmaceutical salts of a factor xa inhibitor
01/16/14Boronate ester compounds and pharmaceutical compositions thereof
01/09/14Derivatives of 1-amino-2-cyclopropylethylboronic acid
12/26/13Heteroaryl compounds useful as inhibitors of e1 activating enzymes
12/19/13Substituted pyrrolo]2,3-d]pyrimidines
Patent Packs
12/12/13Proteasome inhibitors
12/12/13Proteasome inhibitors
11/28/13Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
11/21/13Boronic ester and acid compounds, synthesis and uses
10/31/13Anti-gcc antibody molecules and methods for use of same
10/10/13Heteroaryls and uses thereof
08/22/13Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
08/22/13Heteroaryls and uses thereof
08/15/13Methods of synthesizing factor xa inhibitors
07/04/13Benzamides and related inhibitors of factor xa
06/27/13Boronate ester compounds and pharmaceutical compositions thereof
06/27/13Inhibitors of e1 activating enzymes
06/27/13Heteroaryls and uses thereof
06/27/13Heteroaryls and uses thereof
06/27/13Heteroaryls and uses thereof
06/13/13Inhibitors of nedd8-activating enzyme
05/16/13Secreted proteins and uses thereof
05/16/13Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
05/09/13Administration of a nedd8-activating enzyme inhibitor and hypomethylating agent
04/25/13Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
03/28/13Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor
03/14/13Novel pharmaceutical salts and polymorphs of a factor xa inhibitor
03/14/13Compounds useful as raf kinase inhibitors
03/07/13Antibodies that bind ov064 and methods of use therefor
02/14/13Ccr1 inhibitors useful for the treament of multiple myeloma and other disorders
01/31/13Novel multidrug resistance-associated polypeptide
01/24/13Mucosal vascular addressins and uses thereof
01/10/13Methods for the identification, assessment, and treatment of patients with cancer therapy
01/03/13Synthesis of boronic ester and acid compounds
12/06/12Thiolactams and uses thereof
Patent Packs
11/29/12Thiolactams and uses thereof
11/08/12Formulation for anti-alpha4beta7 antibody
10/25/12Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
10/18/12Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
10/11/12Inhibitors of e1 activating enzymes
09/06/12Novel molecules of the card-related protein family and uses thereof
08/23/12Heteroaryls and uses thereof
08/23/12Compounds useful as antagonists of ccr2
08/16/12Compounds useful as antagonists of ccr2
08/09/12Heteroaryls and uses thereof
07/12/12Heteroaryls and uses thereof
07/12/12Factor xa inhibitors
07/12/12Lactam compounds useful as protein kinase inhibitors
07/05/12Compositions and methods for the treatment and diagnosis of immune disorders
07/05/12Heteroaryls and uses thereof
06/28/12Substituted hydroxamic acids and uses thereof
06/14/12Compositions and methods for the diagnosis and treatment of immune disorders
06/07/12Heteroaryls and uses thereof
05/10/12Administration of nedd8-activating enzyme inhibitor
04/19/12Substituted hydroxamic acids and uses thereof
Social Network Patent Pack
04/12/12Factor xa inhibitors
04/05/12Benzamides and related inhibitors of factor xa
03/22/12Heteroaryl compounds useful as inhibitors of e1 activating enzymes
03/15/12Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
03/01/12Substituted hydroxamic acids and uses thereof
02/23/12Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
02/23/12Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
01/19/12Substituted hydroxamic acids and uses thereof
01/05/12Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor
12/29/11Methods of synthesizing factor xa inhibitors
12/22/11Aurora kinase inhibitors for inhibiting mitotic progression
12/22/11Aurora kinase inhibitors for inhibiting mitotic progression
12/22/11Ccr9 inhibitors and methods of use thereof
12/15/11Delta3, fthma-070, tango85, tango77, spoil, neokine, tango129, and integrin alpha subunit protein and nucleic acid molecules and uses thereof
12/15/11Boronic ester and acid compounds, synthesis and uses
12/08/11Proteasome inhibitors
11/24/11Substituted hydroxamic acids and uses thereof
11/17/11Antibodies which bind human cxcr3
10/20/11Thiolactams and uses thereof
10/13/11Substituted hydroxamic acids and uses thereof
Social Network Patent Pack
10/06/11Derivatives of 1-amino-2-cyclopropylethylboronic acid
10/06/11Crystalline forms of sodium 4--2-methoxybenzoate
09/29/11Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
09/22/11Novel narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, and narc 25 molecules and uses therefor
09/01/11Substituted hydroxamic acids and uses thereof
09/01/11Substituted hydroxamic acids and uses thereof
07/28/11Novel human transferase family members and uses thereof
07/21/11Salts and crystalline forms of a factor xa inhibitor
07/14/11Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor
07/07/11Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor
06/30/11Factor xa inhibitors
06/30/11Crystalline forms of a factor xa inhibitor
06/23/11Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
06/23/11Methods of preparing factor xa inhibitors and salts thereof
06/09/11Inhibitors of e1 activating enzymes
05/26/11Compositions and methods for the treatment and diagnosis of immune disorders
05/19/11Factor xa inhibitors
05/12/1114189, a novel human kinase and uses thereof
05/12/11Methods and kits for monitoring the effects of immunomodulators on adaptive immunity
05/05/11Novel kinases and uses thereof
05/05/11Methods and products for diagnosing autoimmune disease and gastric cancer linked with atrophic gastritis
04/07/11Secreted proteins and uses thereof
03/24/112-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
03/17/11Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
02/24/11Substituted hydroxamic acids and uses thereof
02/17/11Lactam compounds useful as protein kinase inhibitors
02/17/11Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
02/17/11Substituted hydroxamic acids and uses thereof
01/27/11Novel multidrug resistance-associated polypeptide
01/27/11Novel italy, lor-2, strife, trash, bdsf, lrsg, and stmst protein and nucleic acid molecules and uses therefor
Social Network Patent Pack
01/27/11Hydrochloride salt of ((1s,2s,4r)-4--2-hydroxycyclopentyl)methyl sulfamate
01/27/11Process improvement
12/23/10Ccr9 inhibitors and methods of use thereof
12/09/10Solid pharmaceutical compositions and processes for their production
12/09/10Alpha carbolines and uses thereof
11/25/10Methods of diagnosing and treating cancer
11/25/10Nucleic acids encoding humanized immunoglobulin that binds alpha4beta7 integrin
11/25/10Benzamides and related inhibitors of factor xa
11/18/10Novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, narc 25, 86604 and 32222 molecules and uses therefor
11/18/10Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
11/18/10Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
11/04/10Process improvement using tmeda
11/04/10Novel secreted immunomodulatory proteins and uses thereof
11/04/10Ccr9 inhibitors and methods of use thereof
10/28/10Angiotensin converting enzyme homolog and uses therefor
09/30/10Factor xa inhibitors
09/23/10Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
09/16/10Humanized anti-ccr2 antibodies and methods of use therefor
09/16/10Factor xa inhibitors
09/16/10Compounds useful as chemokine receptor antagonists
08/19/10Human proteins responsible for nedd8 activation and conjugation
08/12/10Proteasome inhibitors
08/05/10Preparation of aminotetralin compounds
08/05/10Methods of synthesizing pharmaceutical salts of a factor xa inhibitor
07/22/10Combination of aurora kinase inhibitors and anti-cd20 antibodies
07/15/10Crystal forms of 4-[6-methoxy-7(3-piperidin-1-yl-propoxy) quinazoline-4yl) piperazine-1-carboxylic acid (4-isopropoxyphenyl)-amide
07/15/10Thiolactams and uses thereof
07/08/10Synthesis of boronic ester and acid compounds
06/17/1026199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Millennium Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Millennium Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';